On a consolidated basis, Revenue dropped 35% YoY to INR 4079mnwith RACs contributing 36% of the revenue & Components and Mobility business forming the rest.Gross marg..
Buy Cipla Ltd For Target Rs.856 - HDFC Securities
Globally, Cipla is the second largest inhaler (MDI + DPI- metered dose and dry powder) selling ..
IPM growth negative; expect strong FY22E
As per AIOCD, the India Pharma Market (IPM) reported yet another month pf decline with 2.2% drop in IPM sales primarily drive..
Foray into sterile injectables
Strides Pharma Science (Strides) has announced plans to re-enter sterile injectable business through SteriScience which would be a dedi..
Robust show in CRAMS and specialty business; margins surge
* Navin Fluorine’s (NFIL) consolidated Q2FY21 revenue rose 17% yoy to Rs3.2bn, b..
Good quarter, lower SG&A cost is encouraging
Dr. Reddys' Q2 Rev/PAT beat estimates by 4%/20% driven by strong growth across markets and lower tax rate. Tight c..
BENGALURU - Shares of India's Gland Pharma got off to a flying start in their market debut on Friday, rising as much as 23% and highlighting a strong appetite f..
New launches to drive medium-term growth
To outperform market in base therapies is another focus area
We attended GSK Pharma’s (GLXO) virtual analyst meet t..
* The stock has formed a higher base at the 50 days EMA (| 169) and the rising demand line joining lows since May 2020 (| 97) highlighting stren..
Development of complex pipeline on track
Steady US base business; EU outlook gradually improving
* The Aurobindo Pharma (ARBP) stock has corrected ~20% over the p..
Covid-19 impacts Q1; outlook upbeat…
Q1 revenues fell 13.2% YoY to | 1893 crore. Pharma business de-grew 17.5% YoY to | 1096 crore due to lower Radiopharma, al..
An emerging injectable franchise
We upgrade Aurobindo to BUY with revised TP of Rs1,030, based on 15x based on Sep’22 EPS. We revise our FY21/22 est..
Rupee falls 10 paise to 73.94 against US dollar in early trade
Rate decision, US stimulus likely constraints to rupee's further appreciation
NCLT approves sale of IL&FS education arm to LEHL
Hyundai Motor India adds new Board members
Vodafone Idea board to mull raising funds post AGR verdict
NCDEX Turmeric Future price has traded bearish during the month of November - Choice Broking
MCX Aluminium futures traded mixed to bullish during the month of November - Choice Broking
13000 finally a reality, banking propels the move By Sameet Chavan, Angel Broking
Buy Crude Oil Above 3250 SL BELOW 3200 TGT 3320/3350 - Axis Securities
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface